Prednisolone sodium phosphate and Disease recurrence - a phase IV clinical study of FDA data

Summary:

Disease recurrence is reported as a side effect among people who take Prednisolone sodium phosphate (prednisolone sodium phosphate), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Lasix, and have Eczema.

The phase IV clinical study analyzes which people have Disease recurrence when taking Prednisolone sodium phosphate. It is created by eHealthMe based on reports of 2,239 people who have side effects when taking Prednisolone sodium phosphate from the FDA, and is updated regularly.

What is Prednisolone sodium phosphate?

Prednisolone sodium phosphate has active ingredients of prednisolone sodium phosphate. It is often used in ulcerative colitis. eHealthMe is studying from 2,310 Prednisolone sodium phosphate users. Check the latest studies of Prednisolone sodium phosphate.

What is Disease recurrence?

Disease recurrence is found to be associated with 1,243 drugs and 1,551 conditions by eHealthMe. Check the latest studies of Disease recurrence.

On Jul, 23, 2026

2,239 people reported to have side effects when taking Prednisolone sodium phosphate.
Among them, 19 people (0.85%) have Disease recurrence.

Could Prednisolone sodium phosphate cause Disease recurrence?

Among these 19 people:

How long have people been on Prednisolone sodium phosphate when they have Disease recurrence? *

What is the gender of people who have Disease recurrence when taking Prednisolone sodium phosphate? *

female: 6.25 %
male: 93.75 %

What is the age of people who have Disease recurrence when taking Prednisolone sodium phosphate? *

What are other drugs people take besides Prednisolone sodium phosphate? *

Zopiclone: 17 people, 89.47%
Altace: 17 people, 89.47%
Lasix: 17 people, 89.47%
Celebrex: 15 people, 78.95%
Zocor: 14 people, 73.68%
Nitroglycerin: 10 people, 52.63%
Acetaminophen: 10 people, 52.63%
Esomeprazole Magnesium: 9 people, 47.37%
Clobazam: 9 people, 47.37%
Omeprazole: 9 people, 47.37%

What are other side effects people have besides Disease recurrence? *

Ischaemic Stroke (stroke; caused by an interruption in the flow of blood to the brain): 17 people, 89.47%
Facial Paralysis (loss of function of face muscle): 17 people, 89.47%
Areflexia (absence of a reflex): 17 people, 89.47%
Brain Scan Abnormal: 17 people, 89.47%
Hemiplegia (paralysis of one side of the body): 17 people, 89.47%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 17 people, 89.47%
Cerebral Artery Thrombosis (clot formation in brain blood vessels): 17 people, 89.47%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 17 people, 89.47%
Respiratory Distress (difficulty in breathing): 17 people, 89.47%
Nausea (feeling of having an urge to vomit): 17 people, 89.47%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 1 person, 5.26%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisolone sodium phosphate and have Disease recurrence?

- Check whether Disease recurrence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prednisolone sodium phosphate:

Prednisolone sodium phosphate (2,310 reports)

Browse all side effects of Prednisolone sodium phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disease recurrence:

Disease recurrence (1,244 drugs)

Browse all the conditions that are associated with Disease recurrence:

Disease recurrence (1,551 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prednisolone sodium phosphate (the active ingredients of Prednisolone sodium phosphate) and Prednisolone sodium phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.